Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications
- PMID: 40070487
- PMCID: PMC11893992
- DOI: 10.3389/fnhum.2025.1544994
Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications
Erratum in
-
Corrigendum: Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications.Front Hum Neurosci. 2025 May 6;19:1612584. doi: 10.3389/fnhum.2025.1612584. eCollection 2025. Front Hum Neurosci. 2025. PMID: 40395686 Free PMC article.
Abstract
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology. Innovative applications are currently being explored in stroke, disorders of consciousness, and sleep, while established treatments for movement disorders like Parkinson's disease are being refined with adaptive stimulation. Neuromodulation is solidifying its role in treating psychiatric disorders such as depression and obsessive-compulsive disorder, particularly for patients with treatment-resistant symptoms. We estimate that 300,000 leads have been implanted to date for neurologic and neuropsychiatric indications. Magnetoencephalography has provided insights into the post-DBS physiological changes. The field is also critically examining the ethical implications of implants, considering the long-term impacts on clinicians, patients, and manufacturers.
Keywords: Parkinson’s disease; deep brain stimulation; depression; epilepsy; neuromodulation; obsessive-compulsive disorder; sleep; stroke.
Copyright © 2025 Martinez-Nunez, Rozell, Little, Tan, Schmidt, Grill, Pajic, Turner, de Hemptinne, Machado, Schiff, Holt-Becker, Raike, Malekmohammadi, Pathak, Himes, Greene, Krinke, Arlotti, Rossi, Robinson, Bahners, Litvak, Milosevic, Ghatan, Schaper, Fox, Gregg, Kubu, Jordano, Cascella, Nho, Halpern, Mayberg, Choi, Song, Cha, Alagapan, Dosenbach, Gordon, Ren, Liu, Kalia, Hescham, Kusyk, Ramirez-Zamora, Foote, Okun and Wong.
Conflict of interest statement
AH-B and RR were employed by Medtronic Inc. DG was employed by NeuroPace, Inc. LKr, MA, and LR were employed by Newronika SpA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures











References
-
- Anjum M. F., Smyth C., Zuzuárregui R., Dijk D. J., Starr P. A., Denison T., et al. . (2024). Multi-night cortico-basal recordings reveal mechanisms of NREM slow-wave suppression and spontaneous awakenings in Parkinson’s disease. Nat. Commun. 15:1793. doi: 10.1038/s41467-024-46002-7, PMID: - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources